Caxton Associates LP Innoviva, Inc. Transaction History

Caxton Associates LP

$3.12 Billion
Q4 2024

A detailed history of Caxton Associates LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 25,480 shares of INVA stock, worth $469,596. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,480

Previous 27,524 7.43%

Holding current value

$469,596

Previous $531,000 16.76%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$17.35 - $20.32 $35,463 - $41,534	-2,044 Reduced 7.43%	25,480 $442,000
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $1.32 Million - $1.62 Million	-80,753 Reduced 74.58%	27,524 $531,000
Q2 2024 Aug 14, 2024	BUY	$14.4 - $16.4 $1.05 Million - $1.19 Million	72,716 Added 204.48%	108,277 $1.78 Million
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $277,746 - $320,095	19,076 Added 115.72%	35,561 $541,000
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $203,095 - $268,210	16,485 New	16,485 $264,000
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $93,297 - $118,252	8,695 Added 57.34%	23,860 $268,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $178,947 - $208,973	15,165 New	15,165 $200,000
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $1.29 Million - $1.8 Million	-90,391 Reduced 65.34%	47,944 $708,000
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $1.44 Million - $1.9 Million	93,807 Added 210.67%	138,335 $2.68 Million
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $581,535 - $767,662	44,528 New	44,528 $744,000
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $408,386 - $572,847	-39,534 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $27,690 - $36,776	-2,410 Reduced 5.75%	39,534 $553,000
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $166,774 - $313,189	-20,564 Reduced 32.9%	41,944 $493,000
Q4 2019 Feb 14, 2020	BUY	$10.28 - $14.38 $642,582 - $898,865	62,508 New	62,508 $885,000
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $245,095 - $320,590	-17,557 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $239,301 - $275,644	17,557 New	17,557 $268,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $248,910 - $306,448	-18,037 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $211,574 - $266,045	18,037	18,037 $256,000

Others Institutions Holding INVA

# of Institutions

260

Shares Held

75.2M

Call Options Held

2.3K

Put Options Held

2.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.28B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account

Caxton Associates LP Innoviva, Inc. Transaction History